Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Dermatology and Therapy
Dermatology
2012English

Safety, Efficacy, and Patient Acceptability of Imiquimod for Topical Treatment of Actinic Keratoses

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2011English

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Current Dermatology Reports
Dermatology
2013English

Prevalence of Actinic Keratoses and Associated Factors in a Representative Sample of the Italian Adult Population

Archives of Dermatology
2006English

Systematic Review and Cost-Effectiveness Analysis of Drug Used in Obesity Treatment in Brazil, Under Health System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Imiquimod 5% Cream for the Treatment of Actinic Keratosis of the Eyelid

Beyoglu Eye Journal
2017English

Cost Effectiveness Analysis of Varenicline Use for Smoking Cessation in the City of São Paulo From the Public Health System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pmd75 - The Cost-Effectiveness of Transcatheter Aortic Valve Implantation: Exploring the Italian National Health System Perspective and Considering Different Patients Risk Groups

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms

Journal of the American Academy of Dermatology
Dermatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy